Bifidobacterium infantis Metabolizes 2′Fucosyllactose-Derived and Free Fucose Through a Common Catabolic Pathway Resulting in 1,2-Propanediol Secretion
Human milk oligosaccharides (HMOs) enrich beneficial bifidobacteria in the infant gut microbiome which produce molecules that impact development and physiology. 2′fucosyllactose (2′FL) is a highly abundant fucosylated HMO which is utilized by Bifidobacterium longum subsp. infantis, despite limited s...
Main Authors: | Liv R. Dedon, Ezgi Özcan, Asha Rani, David A. Sela |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2020.583397/full |
Similar Items
-
Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infantis Physiology
by: Ezgi Özcan, et al.
Published: (2018-05-01) -
Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
by: Yvan Vandenplas, et al.
Published: (2018-08-01) -
Multi-Path Optimization for Efficient Production of 2′-Fucosyllactose in an Engineered Escherichia coli C41 (DE3) Derivative
by: Zhijian Ni, et al.
Published: (2020-12-01) -
Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
by: Thomas Grabinger, et al.
Published: (2019-06-01) -
Increased Antibody Response to Fucosylated Oligosaccharides and Fucose-Carrying Bacteroides Species in Crohn’s Disease
by: Katharina Kappler, et al.
Published: (2020-07-01)